KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biocryst Pharmaceuticals (BCRX) Return on Assets (2023 - 2025)

Biocryst Pharmaceuticals (BCRX) has disclosed Return on Assets for 8 consecutive years, with 0.11% as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Return on Assets rose 31.0% year-over-year to 0.11%, compared with a TTM value of 0.11% through Mar 2025, up 31.0%, and an annual FY2024 reading of 0.18%, changed N/A over the prior year.
  • Return on Assets was 0.11% for Q1 2025 at Biocryst Pharmaceuticals, up from 0.18% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.02% in Q2 2023 and bottomed at 0.48% in Q3 2024.
  • Average Return on Assets over 3 years is 0.23%, with a median of 0.18% recorded in 2024.
  • The sharpest move saw Return on Assets crashed -46bps in 2024, then soared 31bps in 2025.
  • Year by year, Return on Assets stood at 0.33% in 2023, then soared by 45bps to 0.18% in 2024, then soared by 39bps to 0.11% in 2025.
  • Business Quant data shows Return on Assets for BCRX at 0.11% in Q1 2025, 0.18% in Q4 2024, and 0.48% in Q3 2024.